Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TriSalus Life Sciences, Inc. - Common Stock
(NQ:
TLSI
)
3.260
-0.190 (-5.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
393,473
Open
3.460
Bid (Size)
2.960 (100)
Ask (Size)
3.450 (700)
Prev. Close
3.450
Today's Range
3.250 - 3.508
52wk Range
2.200 - 7.950
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
May 20, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 20, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Performance
YTD
-46.6%
-46.6%
1 Month
-29.6%
-29.6%
3 Month
-34.7%
-34.7%
6 Month
-41.3%
-41.3%
1 Year
-41.4%
-41.4%
More News
Read More
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
May 19, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
TriSalus Life Sciences (NASDAQ:TLSI) Swings to Surprise Net Profit in Q1, But Revenue Miss Tempers Outlook
↗
May 12, 2026
Via
Chartmill
TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q4 Revenue Beat and Narrowed Losses
↗
March 05, 2026
Via
Chartmill
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
May 19, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
In today's session, these stocks are experiencing unusual volume.
↗
May 19, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 19, 2026
Via
Chartmill
TriSalus (TLSI) Q1 2026 Earnings Transcript
↗
May 14, 2026
Via
The Motley Fool
Wednesday's session: top gainers and losers
↗
May 13, 2026
Via
Chartmill
What's going on in today's session
↗
May 13, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 13, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
May 13, 2026
Via
Chartmill
TriSalus Life Sciences Q1 Earnings Call Highlights
↗
May 12, 2026
Via
MarketBeat
Topics
Earnings
TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth
May 12, 2026
From
TriSalus Life Sciences
Via
Business Wire
Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance
May 12, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
May 04, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
April 28, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
April 09, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
April 07, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models
March 18, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus (TLSI) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Via
The Motley Fool
Topics
Earnings
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
March 05, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
February 25, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering
February 20, 2026
From
TriSalus Life Sciences
Via
Business Wire
Frequently Asked Questions
Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
The current price of TriSalus Life Sciences, Inc. - Common Stock is 3.260
When was TriSalus Life Sciences, Inc. - Common Stock last traded?
The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 05/22/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today